Annovis Bio
Price & Volume
Stats
See more52W Range | $1.04-$5.50 |
Market Cap | $51.6M |
Shares Short | 6M |
Financials
See moreRevenue (12 Mos) | $0 |
Revenue Growth (YoY) | 0% |
Gross Profit (12 Mos) | $0 |
Diluted EPS | -$1.75 |
News
See moreYahoo Finance • 7 days ago
Parkinson's Disease Market Poised for Expansion During the Forecast Period (2026-2036) Amid JUVMO Approval and Emerging Therapeutic Innovations | DelveInsight
Yahoo Finance • 2 months ago
Real Parkinson’s Disease Hope from Jupiter Neurosciences
Yahoo Finance • 2 months ago
The Next Billion-Dollar Opportunity in Alzheimer's Disease Market: 6 Pipeline Therapies to Watch | DelveInsight
Yahoo Finance • 3 months ago
Annovis Appoints Cheng Fang, Ph.D., as Chief Scientific Officer
About
CEO | Dr. Maria L. Maccecchini Ph.D. |
CFO | Dr. Maria L. Maccecchini Ph.D. |
Address | 101 Lindenwood Drive, Malvern, PA, United States, 19355 |
Sector | Healthcare |
Industry | Biotechnology |
Full-Time Employees | 7 |